Companion Animal Protection Against Cruel Testing Act
The source supplies the latest action, but no lifecycle stage.
Latest action (21 Sep 2026): Referred to the House Committee on Energy and Commerce.
What this bill does
H.R. 10522, the Companion Animal Protection Against Cruel Testing Act, would prohibit the use of Department of Health and Human Services (HHS) funds for biomedical research involving live dogs and cats. The bill defines biomedical research broadly, but excludes certain activities such as routine veterinary care, observational studies without intervention, and research specifically for the health of dogs or cats. It also includes provisions for the disposition of animals no longer needed for research, requiring efforts to rehome them.
The bill affects recipients of HHS funding for biomedical research, including institutions of higher education, nonprofit organizations, and research institutes. These recipients would be required to certify compliance with the new rules and maintain records to demonstrate adherence. The Secretary of Health and Human Services would have authority to waive the prohibition under specific emergency circumstances, such as a public health or national security emergency, provided certain conditions are met and Congress is notified.
This bill was introduced in the House of Representatives and has been referred to the Committee on Energy and Commerce. As an introduced bill, it has not yet been passed by either chamber of Congress and would require further committee review, potential amendments, and votes in both the House and the Senate before it could be sent to the President to be signed into law.
Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.
Official summary
Companion Animal Protection Against Cruel Testing Act
This bill prohibits the use of funds made available to covered federal agencies for any biomedical research activity involving a live dog or cat. Covered agencies are agencies or offices within the Department of Health and Human Services (HHS) that award, administer, or expend federal funds for biomedical research.
This prohibition also applies to activities that materially facilitate biomedical research involving a live dog or cat (e.g., salaries, facility maintenance, and administrative support primarily related to such research). It does not apply to transportation and rehousing of animals previously used in biomedical research or observational activities that do not involve alteration of an animal’s normal environment or medical care.
The prohibition applies to federal funds obligated or expended beginning 180 days after the bill is enacted. HHS may waive the prohibition in limited circumstances if necessary to respond to a specified emergency.
Recipients of funding from covered agencies must make reasonable efforts to transfer dogs and cats no longer needed for research to rescue organizations or other appropriate entities. Further, recipients may only euthanize an animal if a veterinarian has determined euthanasia is necessary for animal welfare or public safety.
If HHS determines that a recipient has violated a provision of the bill, it may withhold further funding to the recipient, recover funds expended in violation, and impose other administrative remedies.
Finally, the Government Accountability Office must report to Congress on the bill's implementation within three years after the bill takes effect.
Timeline
21 Sep 2026
Referred to the House Committee on Energy and Commerce.
Common questions
- What does H.R. 10522 do?
- H.R. 10522, the Companion Animal Protection Against Cruel Testing Act, would prohibit the use of Department of Health and Human Services (HHS) funds for biomedical research involving live dogs and cats. The bill defines biomedical research broadly, but excludes certain activities such as routine veterinary care, observational studies without intervention, and research specifically for the health of dogs or cats. It also includes provisions for the disposition of animals no longer needed for research, requiring efforts to rehome them. The bill affects recipients of HHS funding for biomedical research, including institutions of higher education, nonprofit organizations, and research institutes. These recipients would be required to certify compliance with the new rules and maintain records to demonstrate adherence. The Secretary of Health and Human Services would have authority to waive the prohibition under specific emergency circumstances, such as a public health or national security emergency, provided certain conditions are met and Congress is notified. This bill was introduced in the House of Representatives and has been referred to the Committee on Energy and Commerce. As an introduced bill, it has not yet been passed by either chamber of Congress and would require further committee review, potential amendments, and votes in both the House and the Senate before it could be sent to the President to be signed into law.
- Has H.R. 10522 become law?
- The source does not supply a confirmed lifecycle stage for H.R. 10522. Check the latest action and official source below.
- Who sponsored H.R. 10522?
- H.R. 10522 was sponsored by Rep. Langworthy, Nicholas A. [R-NY-23] (R-NY), with 20 cosponsors.
- What's the latest action on H.R. 10522?
- Referred to the House Committee on Energy and Commerce. (21 Sep 2026).
Related bills in Science, Technology, Communications
Accelerating Broadband Permits Act of 2026
Disaster Communications Coordination and Preparedness Act
Mystic Alerts Act
Bots Research Act
More bills from Rep. Langworthy, Nicholas A. [R-NY-23]
Biosimilars Access and Affordability Act
Surge to Save Newborns Act
FLOWS Act
CHECK Act of 2026
Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.